Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (61-70 of 434) with videos related to

Pageof 44
Sort By:
Rheumatology (Oxford, England)|October 3, 2017
Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitisFiona A Pearce, Anthea Craven, Peter A Merkel, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Severe Small-Vessel Vasculitis Temporally Associated With Administration of UstekinumabKelly M MacArthur, Peter A Merkel, Abby S Van Voorhees, et al.
Arthritis and Rheumatism|July 13, 2004
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritisGary S Hoffman, Peter A Merkel, Richard D Brasington, et al.
Rheumatology (Oxford, England)|May 17, 2021
Temporal artery biopsy revealing marginal zone lymphoma in a patient with eosinophilic granulomatosis with polyangiitisShubhasree Banerjee, Franz Fogt, Dale M Frank, et al.
Seminars in Arthritis and Rheumatism|April 22, 2011
Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitisPeter C Grayson, J Mark Sloan, John L Niles, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern SwedenAladdin J Mohammad, Jan-Åke Nilsson, Lennart T H Jacobsson, et al.
Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.
The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.
Arthritis Care & Research|June 1, 2020
Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic PolyangiitisPeter A Merkel, John L Niles, Lester E Mertz, et al.
American Journal of Respiratory and Critical Care Medicine|August 21, 2015
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial HypertensionRennie L Rhee, Nicole B Gabler, Sapna Sangani, et al.
Pageof 44

Showing results (61-70 of 434) with videos related to

Sort By:
Pageof 44
Rheumatology (Oxford, England)|October 3, 2017
Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitisFiona A Pearce, Anthea Craven, Peter A Merkel, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Severe Small-Vessel Vasculitis Temporally Associated With Administration of UstekinumabKelly M MacArthur, Peter A Merkel, Abby S Van Voorhees, et al.
Arthritis and Rheumatism|July 13, 2004
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritisGary S Hoffman, Peter A Merkel, Richard D Brasington, et al.
Rheumatology (Oxford, England)|May 17, 2021
Temporal artery biopsy revealing marginal zone lymphoma in a patient with eosinophilic granulomatosis with polyangiitisShubhasree Banerjee, Franz Fogt, Dale M Frank, et al.
Seminars in Arthritis and Rheumatism|April 22, 2011
Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitisPeter C Grayson, J Mark Sloan, John L Niles, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern SwedenAladdin J Mohammad, Jan-Åke Nilsson, Lennart T H Jacobsson, et al.
Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.
The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.
Arthritis Care & Research|June 1, 2020
Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic PolyangiitisPeter A Merkel, John L Niles, Lester E Mertz, et al.
American Journal of Respiratory and Critical Care Medicine|August 21, 2015
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial HypertensionRennie L Rhee, Nicole B Gabler, Sapna Sangani, et al.
Pageof 44